Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology)

BACKGROUND: We tested the association of colon tumour sidedness with prognosis and with molecular subtypes recently shown to be predictive of oxaliplatin benefit in stage III colon cancer. METHODS: NSABP/NRG C-07 trial (N=1603) was used to determine association of tumour sidedness with molecular sub...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, S Rim, Song, Nan, Yothers, Greg, Gavin, Patrick G, Allegra, Carmen J, Paik, Soonmyung, Pogue-Geile, Katherine L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846062/
https://www.ncbi.nlm.nih.gov/pubmed/29241223
http://dx.doi.org/10.1038/bjc.2017.448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846062/
https://www.ncbi.nlm.nih.gov/pubmed/29241223
http://dx.doi.org/10.1038/bjc.2017.448

Ejemplares similares